Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older who voluntarily agree to take part in the study.
- People who have never taken sleep medication, or who stopped taking sleep medication at least 2 weeks before joining the study.
- People who have been formally diagnosed with insomnia according to standard psychiatric guidelines (DSM-V), meaning they experience trouble falling asleep, staying asleep, or waking too early — happening at least 3 nights per week, for at least 3 months, affecting daily life, and not caused by another condition or substance.
- People who are able to understand Vietnamese.
- People who also meet the traditional medicine diagnosis of "Heart-Spleen dual deficiency syndrome," which requires a specific combination of sleep-related symptoms (such as very light or broken sleep, frequent nightmares, and early waking), plus at least 2 of the following: palpitations, forgetfulness, mental tiredness, poor appetite, or a pale complexion — along with at least 2 further symptoms such as dizziness, blurred vision, limb weakness, or digestive issues — as well as specific tongue and pulse findings assessed by a practitioner (confirm with trial site).
Who may not be able to join:
- People who have been diagnosed with another sleep disorder, such as sleep apnea or narcolepsy.
- People who have previously been diagnosed with a neurological or psychiatric condition, such as anxiety disorder, depression, obsessive-compulsive disorder, autism spectrum disorder, or REM sleep behaviour disorder.
- People who are currently taking antidepressants or other psychiatric medications.
- People who are already taking part in another clinical trial involving behavioural, psychological, or complementary medicine treatments during the same period.
- People who decide they no longer wish to continue participating.
- People who experience uncomfortable reactions during the study, such as fainting near needles, nausea, headache, dizziness, or sweating.
- People whose condition gets significantly worse or who develop new health complications during the study.
- People who are unable to follow the treatment plan as required by the study protocol.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +84 946043639
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Insomnia Associated with Heart-Spleen Deficiency; Insomnia Associated with Heart-Spleen Deficiency
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.